Stay updated on Influenza Prevention with Self-Amplifying RNA Clinical Trial

Sign up to get notified when there's something new on the Influenza Prevention with Self-Amplifying RNA Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Influenza Prevention with Self-Amplifying RNA Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page shows a Revision: v3.3.2 and removes Revision: v3.2.0. This is a minor site template update and does not affect study content such as the title, eligibility criteria, contacts, or results. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-27T04:07:48.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    The government funding lapse notice was removed from the page, removing language about potential delays. The previous notice warned that information may not be up to date and described the NIH Clinical Center's operating status.
    Difference
    0.3%
    Check dated 2025-11-19T21:57:17.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    No additions or deletions were detected on the page. The content appears unchanged.
    Difference
    0.3%
    Check dated 2025-10-29T06:16:35.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    - Added a prominent operating-status notice and a link guidance, and updated the version to v3.2.0. - Removed the previous version tag v3.1.0.
    Difference
    3%
    Check dated 2025-10-07T21:16:56.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Upgrade from v3.0.2 to v3.1.0, updating the page version identifier.
    Difference
    0.1%
    Check dated 2025-09-30T01:37:20.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    Significant deletion of high-importance drug-safety topics (drug safety, counterfeit drugs, pharmaceutical preparations, substandard drugs) indicating a substantial drop in emphasis on safety/regulatory content.
    Difference
    0.3%
    Check dated 2025-09-22T23:28:24.000Z thumbnail image

Stay in the know with updates to Influenza Prevention with Self-Amplifying RNA Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Influenza Prevention with Self-Amplifying RNA Clinical Trial page.